Aurora Cannabis (ACB) Restructuring Costs (2017 - 2025)
Aurora Cannabis (ACB) reported Restructuring Costs of -$2.0 million for Q1 2025, down 165.96% year-over-year from $3.0 million in Q1 2024, and down 350.84% quarter-over-quarter from $780991.4 in Q4 2024.
Aurora Cannabis (ACB) Restructuring Costs (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Restructuring Costs data on file, last reported at -$2.0 million in Q1 2025.
- Restructuring Costs for Q1 2025 came in at -$2.0 million, down 165.96% year-over-year; the trailing twelve-month figure through Mar 2025 was $124973.2 (down 96.86% YoY), and the FY2024 annual result was $5.3 million, down 5.03% from the prior year.
- Restructuring Costs retreated to -$2.0 million in Q1 2025 per ACB's latest filing, from $780991.4 in the prior quarter.
- Over five years, Restructuring Costs peaked at $4.7 million in Q2 2021 and troughed at -$2.0 million in Q1 2025.
- A 5-year average of $648871.7 and a median of $585000.0 in 2022 frame the typical range for Restructuring Costs.
- On a YoY basis, Restructuring Costs climbed as much as 838.56% in 2023 and fell as far as 1133.16% in 2023.
- A 5-year view of Restructuring Costs shows it stood at $209000.0 in 2021, then slumped by 201.52% to -$212170.4 in 2022, then jumped by 838.56% to $1.6 million in 2023, then sank by 50.16% to $780991.4 in 2024, then tumbled by 350.84% to -$2.0 million in 2025.
- Business Quant data shows ACB's Restructuring Costs at -$2.0 million in Q1 2025, $780991.4 in Q4 2024, and $606968.2 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -1.96 Mn |
| Dec 31, 2024 | 780,991.41 |
| Sep 30, 2024 | 606,968.22 |
| Jun 30, 2024 | 696,045.80 |
| Mar 31, 2024 | 2.97 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Sep 30, 2023 | -349,841.39 |
| Dec 31, 2022 | -212,170.45 |
| Sep 30, 2022 | -28,369.61 |
| Jun 30, 2022 | -765,516.48 |
| Mar 31, 2022 | 585,000.00 |
| Dec 31, 2021 | 209,000.00 |
| Sep 30, 2021 | 175,000.00 |
| Jun 30, 2021 | 4.66 Mn |
| Mar 31, 2021 | 801,000.00 |
| Dec 31, 2020 | 5.65 Mn |
| Sep 30, 2020 | 157,588.97 |
| Jun 30, 2020 | -1.71 Mn |
| Mar 31, 2020 | 969,662.96 |
| Dec 31, 2019 | 1.56 Mn |